Skip to main content
. Author manuscript; available in PMC: 2015 Feb 19.
Published in final edited form as: Biomaterials. 2013 Dec 15;35(7):2346–2354. doi: 10.1016/j.biomaterials.2013.11.075

Fig. 4.

Fig. 4

Characterization of albumin conjugates. (A) MALDI-TOF/MS spectra of Alb(Peg4-DBCO)n (n = DOF) conjugates. (B) Change of DOF measured by MALDI-TOF/MS with respect to the molar equiv. of NHS-Peg4-DBCO. (C) MALDI-TOF/MS spectra of Alb–paclitaxel conjugates and Alb–Paclitaxel–DBCO conjugates.